When examining the melanoma panel for a possible association between BRMS1 and FABP7, a significant correlation between nuclear BRMS1 expression (percentage of immunoreactive cells) and the level of FABP7 (p = 0.011) (Table 4) was observed.
The data in the present study indicated that the total expression percentage of integrin αvβ6 and Ets-1 in colorectal cancer was 36.07% and 57.59% respectively.
Similarly, interleukin 2 receptor (IL-2R) expression (percentage of positive cells) was augmented in the presence of m17-1A (15 +/- 3), c17-1A (14 +/- 3) and cSF25 (25 +/- 3) when compared with no antibody (9 +/- 2).
The expression percentages of CD62P and CD63 in plasma were detected using flow cytometry (FCM) while the platelet-activating factor (PAF) levels were determined through enzyme-linked immunosorbent assay (ELISA) method by Wei et al. [67].
BRCA1 mRNA expression was expressed as a percentage of the median expression value measured in the whole group.
The ratio of the optical density of the protein product to the internal control was obtained and was expressed as percentage of the control expression in the Figures.
FOXP3 expression as a percentage of the CD4+ T cell population is a potential prognostic marker of disease progression.
The resulting percentage obtained was used to calculate the CD25 expression as a percentage of the total CD3+CD4+ population (Figure 2).
The percentage of migrated and survived cardiac mesoangioblasts in each recipient organ (engraftment) was calculated by real-time PCR for GFP expression as a percentage of the value corresponding to the total of injected cells, normalized to their respective sham.
The percentage of migrated cardiac mesoangioblasts in each recipient organ was calculated by real-time PCR for GFP expression as a percentage of the value corresponding to the total of injected cells.
